Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery

Colon Cancer Clinical Trial

Official title:

Consequences of Co-Administration of Propofol With Clonidine and Ketamine Throughout Colon Cancer Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05536362
• Other study ID #: Nirvana Ahmed
• Status: Completed
• Phase: Phase 1
• Start date: February 1, 2021
• Est. completion date: February 28, 2022

Study information

• Verified date: October 2022
• Source: Egymedicalpedia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The Study Showed that combining clonidine and ketamine together can increase the likelihood of achieving a sufficient level of anaesthesia while minimizing post-operative discomfort and inflammation.

Description:

This study aimd to determine whether propofol infusion combined with clonidine and ketamine is more efficient in lowering the level of IL-8, preserving operation stability, and dropping post-operative pain and morphine intake.

When paralleled to propofol alone, TIVA employing propofol infusion along with pre-operation clonidine and ketamine is effective at preserving hemodynamic stability, dropping post-operative pain, and dipping morphine intake.

For this study, sixty contestants with ASA physical status I and II, ranging in age from 35 to 65, were scheduled for colon cancer operation lasting longer than 120 minutes. This study excluded participants with a history of heart, renal and liver cell failure, allergic reaction to studied drugs, and history of epilepsy, hemodynamic instability, chronic pain, or mental illness. Using a computer-generated randomization list, the patients were randomly allocated into two groups (30 patients each).

The treated group(Group T),which got intravenous anaesthesia with TCI propofol mixed with clonidine and ketamine, the control group(Group C),which received intravenous anaesthesia with TCI propofol mixed with a placebo (NaCl 0.9%) .A third party was included in this study so neither the researchers nor the research subjects are aware of the intervention which the patients got.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: February 28, 2022
• Est. primary completion date: January 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 35 Years to 65 Years

Eligibility

Inclusion Criteria:

1. ASA physical status I and II

2. Patients with cancer colon

Exclusion Criteria:

1. participants with a history of heart, renal and liver cell failure.

2. allergic reaction to studied drugs, and history of epilepsy,

3. hydrodynamic instability,

4. chronic pain.

5. mental illness.

Related Conditions & MeSH terms

• Colon Cancer
• Colonic Neoplasms
• Pain, Postoperative
• Post Operative Pain

Intervention

Drug:
• TCI Propofol Injection
To decrease postoperative pain after cancer colon surgery

Locations

Country	Name	City	State
Egypt	October 6 University Hospital	Giza	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Egymedicalpedia

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measurement of Post-operative Pain	Assessment of the pain post-operatively in Pediatric patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain, measured in millimetres from the left end bar to the mark placed by the kid on the 10 cm line anchored by happy faces (no pain) to sad faces (severe pain).	24-hour analgesic after surgery